Dementia
Showing 1-1 of 1
Accelerating Medicines Partnership® Program for Alzheimer's Disease (AMP® AD)
Accelerating Alzheimer's Research and Drug Development
The Accelerating Medicines Partnership® Program for Alzheimer's Disease (AMP® AD) is a precompetitive partnership among government, industry, and nonprofit organizations to transform the current model for developing new diagnostics and treatments for Alzheimer's disease.
Accelerating Medicines Partnership (AMP)
Scientific Contacts for AMP AD
Laurie Ryan, Ph.D.
Email Laurie Ryan